Advanced search
Publication Cover
Expert Review of Vaccines Volume 16, 2017 - Issue 11
Submit an article Journal homepage
591
Views
30
CrossRef citations to date
0
Altmetric
Review

Current status and future prospects for the development of substance abuse vaccines

R. David HeekinMenninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USAView further author information
,
Daryl ShorterMenninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA;Research Service Line, Michael E. DeBakey VA Medical Center, Houston, TX, USACorrespondence[email protected]
View further author information
&
Thomas R. KostenMenninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA;Research Service Line, Michael E. DeBakey VA Medical Center, Houston, TX, USAView further author information
Pages 1067-1077 | Received 13 May 2017, Accepted 08 Sep 2017, Published online: 20 Sep 2017

Citations (30)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Rachel Luba, Suky Martinez, Jermaine Jones, Marco Pravetoni & Sandra D Comer. (2023) Immunotherapeutic strategies for treating opioid use disorder and overdose. Expert Opinion on Investigational Drugs 32:1, pages 77-87.
Read now
Muhammet Celik & Brian Fuehrlein. (2022) A Review of Immunotherapeutic Approaches for Substance Use Disorders: Current Status and Future Prospects. ImmunoTargets and Therapy 11, pages 55-66.
Read now
Md Kamal Hossain, Majid Hassanzadeganroudsari & Vasso Apostolopoulos. (2020) Why METH users are at high risk of fatality due to COVID-19 infection?. Expert Review of Vaccines 19:12, pages 1101-1103.
Read now
Florence Thibaut. (2019) Future paths in psychopharmacology
. Dialogues in Clinical Neuroscience 21:2, pages 115-116.
Read now

Articles from other publishers (26)

Bethany Crouse, Carly Baehr, Dustin Hicks & Marco Pravetoni. (2023) IL-4 Predicts the Efficacy of a Candidate Antioxycodone Vaccine and Alters Vaccine-Specific Antibody-Secreting Cell Proliferation in Mice. The Journal of Immunology 210:9, pages 1272-1280.
Crossref
Cheng Hua. 2023. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11. Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11 158 237 .
Theofanis Vavilis, Eleni Stamoula, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas & Georgios Papazisis. (2023) Biopharmaceuticals against substance use disorders – Present and future. European Journal of Pharmacology 944, pages 175587.
Crossref
Rani S. Sellers & Keith Nelson. 2023. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology. Haschek and Rousseaux's Handbook of Toxicologic Pathology, Volume 2 : Safety Assessment Environmental Toxicologic Pathology 335 396 .
Colin N. Haile, Miah D. Baker, Sergio A. Sanchez, Carlos A. Lopez Arteaga, Anantha L. Duddupudi, Gregory D. Cuny, Elizabeth B. Norton, Thomas R. Kosten & Therese A. Kosten. (2022) An Immunconjugate Vaccine Alters Distribution and Reduces the Antinociceptive, Behavioral and Physiological Effects of Fentanyl in Male and Female Rats. Pharmaceutics 14:11, pages 2290.
Crossref
Thomas R. Kosten, Coreen B. Domingo, Colin N. Haile & David A. Nielsen. (2022) A Clinical Trial of Entolimod a TLR-5 Adjuvant for Vaccines Using Diphtheria or Tetanus as Carrier Proteins. Vaccines 10:10, pages 1592.
Crossref
Benedict T. Bloom & Mary-Jessimine Bushell. (2022) Vaccines against Drug Abuse—Are We There Yet?. Vaccines 10:6, pages 860.
Crossref
Thanh Thuy Truong & Thomas R. Kosten. (2022) Current status of vaccines for substance use disorders: A brief review of human studies. Journal of the Neurological Sciences 434, pages 120098.
Crossref
Eric D. Collins. 2022. Substance and Non-Substance Related Addictions. Substance and Non-Substance Related Addictions 161 178 .
Boadie Waid Dunlop & Carolina Medeiros Da Frota Ribeiro. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 305 359 .
Vincent Wartenweiler, Grace Chung, Amy Stewart & Cody Wenthur. (2021) Pharmacy stakeholder reports on ethical and logistical considerations in anti-opioid vaccine development. BMC Medical Ethics 22:1.
Crossref
Thomas R. Kosten & Ismene L. Petrakis. (2020) The Hidden Epidemic of Opioid Overdoses During the Coronavirus Disease 2019 Pandemic. JAMA Psychiatry.
Crossref
Christine Robinson, Valeria Gradinati, Fatima Hamid, Carly Baehr, Bethany Crouse, Saadyah Averick, Marina Kovaliov, Danni Harris, Scott Runyon, Federico Baruffaldi, Mark LeSage, Sandra Comer & Marco Pravetoni. (2020) Therapeutic and Prophylactic Vaccines to Counteract Fentanyl Use Disorders and Toxicity. Journal of Medicinal Chemistry 63:23, pages 14647-14667.
Crossref
Jeffrey A. Lowell, Emre Dikici, Pratibha M. Joshi, Ralf Landgraf, Vance P. Lemmon, Sylvia Daunert, Sari Izenwasser & Pirouz Daftarian. (2020) Vaccination against cocaine using a modifiable dendrimer nanoparticle platform. Vaccine 38:50, pages 7989-7997.
Crossref
Lauren C. Smith & Olivier George. (2020) Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models. Neuropharmacology 178, pages 108225.
Crossref
Bethany Crouse, Christine Robinson, April Huseby Kelcher, Megan Laudenbach, Juan E. Abrahante & Marco Pravetoni. (2020) Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders. npj Vaccines 5:1.
Crossref
Dheeraj Soni, Simon D. Van Haren, Olubukola T. Idoko, Jay T. Evans, Joann Diray-Arce, David J. Dowling & Ofer Levy. (2020) Towards Precision Vaccines: Lessons From the Second International Precision Vaccines Conference. Frontiers in Immunology 11.
Crossref
Virgil Schijns, Alberto Fernández‐Tejada, Žarko Barjaktarović, Ilias Bouzalas, Jens Brimnes, Sergey Chernysh, Sveinbjorn Gizurarson, Ihsan Gursel, Žiga Jakopin, Maria Lawrenz, Cristina Nativi, Stephane Paul, Gabriel Kristian Pedersen, Camillo Rosano, Ane Ruiz‐de‐Angulo, Bram Slütter, Aneesh Thakur, Dennis Christensen & Ed C. Lavelle. (2020) Modulation of immune responses using adjuvants to facilitate therapeutic vaccination. Immunological Reviews 296:1, pages 169-190.
Crossref
E. Andrew Townsend & Matthew L. Banks. (2020) Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic?. CNS Drugs 34:5, pages 449-461.
Crossref
Boadie Waid Dunlop & Carolina Medeiros Da Frota Ribeiro. 2019. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 56 .
M. Heval Ozgen & Stuart Blume. (2019) The continuing search for an addiction vaccine. Vaccine 37:36, pages 5485-5490.
Crossref
Xiang-Zhao Chen, Ru-Yan Zhang, Xi-Feng Wang, Xu-Guang Yin, Jian Wang, Ya-Cong Wang, Xiu Liu, Jing-Jing Du, Zheng Liu & Jun Guo. (2019) Peptide-free Synthetic Nicotine Vaccine Candidates with α-Galactosylceramide as Adjuvant. Molecular Pharmaceutics 16:4, pages 1467-1476.
Crossref
Paul S. Regier, Kyle M. Kampman & Anna Rose Childress. 2020. Substance Use Disorders. Substance Use Disorders 299 322 .
Manuela Kaufmann, Patrik Lenherr, Clemens Walter, Thomas Thurnheer, Thomas Attin, Daniel Wiedemeier & Patrick Schmidlin. (2018) Comparing the Antimicrobial In Vitro Efficacy of Amoxicillin/Metronidazole against Azithromycin—A Systematic Review. Dentistry Journal 6:4, pages 59.
Crossref
M. A. Myagkova & V. S. Morozova. (2018) Vaccines for substance abuse treatment: new approaches in the immunotherapy of addictions. Russian Chemical Bulletin 67:10, pages 1781-1793.
Crossref
Andres Avellaneda-Ojeda, Syed Murtaza, Asim A. Shah & Nidal Moukaddam. (2018) Stimulant Use Disorders. Psychiatric Annals 48:8, pages 372-378.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.